Search

Your search keyword '"M. Intorcia"' showing total 73 results

Search Constraints

Start Over You searched for: Author "M. Intorcia" Remove constraint Author: "M. Intorcia"
73 results on '"M. Intorcia"'

Search Results

1. Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany

2. Bone complications in patients with multiple myeloma in five European countries: A retrospective patient chart review

4. Examination of burden of skeletal-related events in patients naive to denosumab and intravenous bisphosphonate therapy in bone metastases from solid tumors population

5. Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study

6. A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America

7. Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States

8. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database

10. Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control

11. Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates

13. PUK3 TREATMENT EFFECTS IN SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE: A SYSTEMATIC LITERATURE REVIEW

14. GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates

15. Persistencia en el tratamiento para la osteoporosis en pacientes posmenopáusicas en el ámbito de la Atención Primaria

16. Effect of renal impairment (RI) on intravenous bisphosphonates (IVBP) and multiple myeloma (MM) treatment

17. Impact of skeletal-related events on multiple myeloma treatment

19. Grand-4: The German Retrospective Analysis on Persistence in Women with Osteoporosis Treated with Bisphosphonates or Denosumab

21. Patient Characteristics, Skeletal Related Events (SRE) And Renal Impairment (RI) In Patients With Multiple Myeloma (MM): A Patient Chart Audit In EU5

22. Persistence, Compliance And Bisphosphonate Switching In Patients With Multiple Myeloma (MM) In Germany

23. Occurrence Of Skeletal-Related Events (SRE) In Patients With Solid Tumors (ST) And Multiple Myeloma (MM) In Germany: Early Versus Late Initiation of Sre Preventative Agents (SPA)

24. Increased Bone Mineral Density (Bmd) In Postmenopausal Women With Osteoporosis (Op) Receiving Two Denosumab Injections In Routine Clinical Practice In Bulgaria

25. Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis

26. Treatment Persistence in Swedish Women Initiating Denosumab Treatment for Postmenopausal Osteoporosis

28. Skeletal-Related Events (SRES) and Renal Function in Patients with Symptomatic Multiple Myeloma (MM): Results from Belgium, France, Germany, Italy, Spain, Switzerland and The United Kingdom

31. Systematic Review and Meta-Analysis of Persistence With Denosumab in Patients With Osteoporosis

32. Assessing the cost-effectiveness of biologic agents for the management of moderate-to-severe rheumatoid arthritis in anti-TNF inadequate responders in Italy: a modelling approach

34. Persistence & Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary: A Retrospective Cohort Study

35. The Cost of Osteoporotic Fractures in the Romanian Postmenopausal Women Population

37. PMS66 GRAND: THE GERMAN RETROSPECTIVE COHORT ANALYSIS ON NON-ADHERENCE AND ASSOCIATED RISK OF FRACTURES IN OSTEOPOROSIS PATIENTS TREATED WITH ORAL BISPHOSPHONATES

38. PMS39 COST-UTILITY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INSUFFICIENT RESPONSE OR INTOLERANCE TO ANTI-TNF THERAPY IN ITALY: A PROBABILISTIC SENSITIVITY ANALYSIS

39. PMS62 DISCONTINUATION RATE OF THE IST AND IIND ANTI-TUMOR NECROSIS FACTORTHERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY

41. GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab

42. Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice

43. PMS24 OSTEOPOROSIS COSTS IN ITALY. INTERIM RESULTS OF THE BLOCK STUDY

44. PMS68 GRAND: THE GERMAN RETROSPECTIVE COHORT ANALYSIS ON NON-ADHERENCE IN OSTEOPOROSIS PATIENTS TREATED WITH ORAL BISPHOSPHONATES

45. PMS36 COST OF THERAPY OF TUMOR NECROSIS FACTOR BLOCKING AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY

46. PIN14 USING A DECISION SIMULATION MODELTO EVALUATE THE COST-EFFECTIVENESS OF THE TREATMENT OF NUCLEOSIDE-NAÏVE HBE-ANTIGEN NEGATIVE CHB PATIENTS IN ITALY WITH ENTECAVIR AND TEN OF OVIR

47. PMS19 The Economic Burden of Post-Menopausal Osteoporosis and Related Fractures in Greece

49. PMS35 A Cost-Effectiveness Analysis of Denosumab for the Treatment of Post-Menopausal Osteoporosis in Greece

Catalog

Books, media, physical & digital resources